PubRank

Claudio Fiorino

Author PubWeight™ 54.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2012 2.46
2 Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy. Radiother Oncol 2005 2.14
3 Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. Int J Radiat Oncol Biol Phys 2004 1.43
4 Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification. Eur Urol 2013 1.43
5 IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol 2009 1.27
6 Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study. Int J Radiat Oncol Biol Phys 2007 1.23
7 Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 2008 1.21
8 Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy). Int J Radiat Oncol Biol Phys 2003 1.13
9 Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer. Radiother Oncol 2006 1.08
10 Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT. Int J Radiat Oncol Biol Phys 2008 1.07
11 Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study. Radiother Oncol 2009 1.06
12 Predictors of PEG dependence after IMRT±chemotherapy for oropharyngeal cancer. Radiother Oncol 2013 1.03
13 The impact of contouring uncertainty on rectal 3D dose-volume data: results of a dummy run in a multicenter trial (AIROPROS01-02). Int J Radiat Oncol Biol Phys 2003 1.03
14 Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2010 1.03
15 Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC. Radiother Oncol 2008 1.00
16 Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours. Radiother Oncol 2008 1.00
17 Agreement criteria between expected and measured field fluences in IMRT of head and neck cancer: the importance and use of the gamma histograms statistical analysis. Radiother Oncol 2007 0.96
18 Dosimetric predictors of laryngeal edema. Int J Radiat Oncol Biol Phys 2007 0.96
19 Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques. Radiother Oncol 2005 0.94
20 Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison. Radiother Oncol 2010 0.93
21 A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer. Radiother Oncol 2010 0.92
22 Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients. Int J Radiat Oncol Biol Phys 2010 0.91
23 NTCP modeling of subacute/late laryngeal edema scored by fiberoptic examination. Int J Radiat Oncol Biol Phys 2009 0.89
24 Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. Int J Radiat Oncol Biol Phys 2002 0.87
25 Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome. Int J Radiat Oncol Biol Phys 2011 0.87
26 PET-guided dose escalation tomotherapy in malignant pleural mesothelioma. Strahlenther Onkol 2011 0.86
27 Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues. Cancer 2009 0.86
28 Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis. Int J Radiat Oncol Biol Phys 2010 0.86
29 Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer. Radiother Oncol 2011 0.85
30 Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer. Radiother Oncol 2003 0.85
31 Modeling set-up error by daily MVCT for prostate adjuvant treatment delivered in 20 fractions: Implications for the assessment of the optimal correction strategies. Radiother Oncol 2009 0.85
32 Texture analysis for the assessment of structural changes in parotid glands induced by radiotherapy. Radiother Oncol 2013 0.84
33 Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy. Radiother Oncol 2009 0.84
34 Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor. Int J Radiat Oncol Biol Phys 2013 0.84
35 Hypofractionated adjuvant radiotherapy with helical tomotherapy after radical prostatectomy: planning data and toxicity results of a Phase I-II study. Radiother Oncol 2008 0.83
36 Phase I-II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2008 0.83
37 Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors. Radiother Oncol 2011 0.83
38 Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial. Radiother Oncol 2012 0.83
39 High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy. Int J Radiat Oncol Biol Phys 2011 0.82
40 Impact of the radiotherapy technique on the correlation between dose-volume histograms of the bladder wall defined on MRI imaging and dose-volume/surface histograms in prostate cancer patients. Phys Med Biol 2013 0.82
41 Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients. Int J Radiat Oncol Biol Phys 2009 0.82
42 To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2009 0.81
43 Helical tomotherapy for scalp recurrence of primary eccrine mucinous adenocarcinoma. Tumori 2010 0.81
44 Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia. Strahlenther Onkol 2014 0.81
45 Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer. Radiother Oncol 2007 0.81
46 Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy. Radiother Oncol 2010 0.80
47 [11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months. Tumori 2010 0.80
48 Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder. Strahlenther Onkol 2004 0.79
49 Long-term biochemical control of prostate cancer after standard or hyper-fractionation: evidence for different outcomes between low-intermediate and high risk patients. Radiother Oncol 2011 0.79
50 Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy. Radiother Oncol 2011 0.79
51 Feasibility of safe ultra-high (EQD(2)>100 Gy) dose escalation on dominant intra-prostatic lesions (DILs) by Helical Tomotheraphy. Acta Oncol 2011 0.78
52 Fractionation and late rectal toxicity: no reliable estimates of alpha/beta value for rectum can be derived from studies where different volumes of rectum are irradiated at different dose levels: in regard to Brenner (Int J Radiat Oncol Biol Phys 2004;60:1013-1015.). Int J Radiat Oncol Biol Phys 2005 0.78
53 Quality assurance of 3D-CRT: indications and difficulties in their applications. Crit Rev Oncol Hematol 2008 0.77
54 Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison. Radiother Oncol 2013 0.77
55 Correlation between surrogates of bladder dosimetry and dose-volume histograms of the bladder wall defined on MRI in prostate cancer radiotherapy. Radiother Oncol 2012 0.77
56 Characterisation of rectal motion during neo-adjuvant radiochemotherapy for rectal cancer with image-guided tomotherapy: implications for adaptive dose escalation strategies. Acta Oncol 2012 0.75
57 Inter-observer variability in contouring the penile bulb on CT images for prostate cancer treatment planning. Radiat Oncol 2011 0.75
58 A reappraisal of the role of vesicourethral anastomosis biopsy in patient candidates for salvage radiation therapy after radical prostatectomy. Radiother Oncol 2006 0.75
59 An automatic deformable registration method to evaluate parotid glands shrinkage during radiotherapy treatment in Tomotherapy. Conf Proc IEEE Eng Med Biol Soc 2009 0.75
60 Oncology scan--the vision of medical physics. Int J Radiat Oncol Biol Phys 2014 0.75
61 Second Tumor Induction Risk in IMRT for Prostate Cancer: An Unbalanced Comparison Between Surgery and Radiotherapy? Health Phys 2015 0.75
62 Megavoltage CT images of helical tomotherapy unit for radiation treatment simulation: impact on feasibility of treatment planning in a prostate cancer patient with bilateral femoral prostheses. Tumori 2011 0.75
63 Contouring variability of the penile bulb on CT images: quantitative assessment using a generalized concordance index. Int J Radiat Oncol Biol Phys 2012 0.75
64 In-gantry or remote patient positioning? Monte Carlo simulations for proton therapy centers of different sizes. Radiother Oncol 2011 0.75
65 Analysis of serial CT images for studying the RT effects in head-neck cancer patients. Conf Proc IEEE Eng Med Biol Soc 2015 0.75